The Hyperdense Posterior Cerebral Artery Sign
Stroke 37:399-403, Krings,T.,et al, 2006
Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
Intracranial Dural Arteriovenous Fistulas with Retrograde Cortical Venous Drainage: Assessment with Cerebral Blood Volume by Dynamic Susceptibility Contrast Magnetic Resonance Imaging
AJNR 27:1252-1256,1257, Noguchi,K.,et al, 2006
Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006
Amebic Meningoencepahlitis: Spectrum of Imaging Findings
AJNR 27:1217-1221, Singh,P.,et al, 2006
Diffusion-Weighted MR Imaging in Early Diagnosis and Prognosis of Hypoglycemia
AJNR 27:1222-1224, Lo,L.,et al, 2006
MR Imaging and Prognosis of Hypoxic-Ischemic Leukoencephalopathy
Neurocrit Care 4:119-126, Finelli,P. &DiMario,F.J. Jr., 2006
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Nonaneurysmal Convexity Subarachnoid Hemorrhage
Neurocrit Care 4:229-233, Patel,K.C. &Finelli,P.F., 2006
Atypical Appearance of a Primary Central Nervous System Lymphoma
Arch Neurol 63:908-909, Trendelenburg,G.,et al, 2006
Voltage-gated Potassium Channel Antibody-Associated Encephalitis with Basal Ganglia Lesions
Neurol 66:1780-1781, Hiraga,A.,et al, 2006
Primary Dural Lymphomas: A Clinicopathologic Study of Treatment and Outcome in Eight Patients
Neurol 66:1763-1765, Iwamoto,F.M.,et al, 2006
White Matter Alterations in Cerebral Amyloid Angiopathy Measured by Diffusion Tensor Imaging
Stroke 37:1759-1764, Salat,D.H., 2006
The Clinical Features, MRI Findings, and Outcome of Optic Neuritis in Children
Neurol 67:258-262, Wilejto,M.,et al, 2006
Diffusion-Weighted Imaging in Stroke Attributable to Patent Foramen Ovale: Significance of Concomitant Atrial Septum Aneurysm
Stroke 37:2030-2034, Bonati,L.H.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
International Study on Low-Grade Primary Central Nervous System Lymphoma
Ann Neurol 59:755-762, Jahnke,K.,et al, 2006
Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006
Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
Neuropathy Progressing to Myeloneuropathy 20 Years After Partial Gastrectomy
Neurol 66:1451, Everett,C.M.,et al, 2006
Multiple Sclerosis: New Insights and Trends
AJNR 27:954-957, Inglese,M., 2006
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia
AJNR 27:1037-1039, Mascalchi,M.,et al, 2006
Neuropathology of the Neuroradiologist: Rosenthal Fibers
AJNR 27:958-961, Wippold,F., II,et al, 2006
Gadolinium Enhancement of Cauda Equina: A New MR Imaging Finding in the Radiculitic Form of Tick-Borne Encephalitis
AJNR 27:995-997, Marjelund,S.,et al, 2006
Diffusion MRI Abnormalities After Prolonged Febrile Seizures with Encephalopathy
Neurol 66:1304-1309, Takanashi,J.,et al, 2006
Past Adult Lead Exposure is Linked to Neurodegeneration Measured by Brain MRI
Neurol 66:1476-1484,1464, Stewart,W.F.,et al, 2006
Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006
Acute Longitudinal Myelitis as the initial Manifestation of Sjgerns Syndrome
JNNP 77:780, Yamamoto,T.,et al, 2006
Accuracy of Magnetic Resonance Imaging for the Diagnosis of Multiple Sclerosis: Systematic Review
BMJ 332:875-878, Whiting P.,et al, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Persistent Infarct Hyperintensity on Diffusion-Weighted Imaging Late After Stroke Indicates Heterogeneous, Delayed, Infarct Evolution
Stroke 37:1418-1423, Rivers,C.S.,et al, 2006
Vasculopathic Changes in the Cerebral Arterial System with Neurobrucellosis
AJNR 27:384-386, Adaletli,I.,et al, 2006
Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006
Remote Cerebellar Hemorrhage
AJNR 27:387-390, Amini,A.,et al, 2006
CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006
Diffusion MR Imaging in a Case of Acute Ischemic Optic Neuropathy
AJNR 27:255-257, Al-Shafai,L.S.&Mikulis,D.J., 2006
Hyperostosis Frontalis Interna
Arch Neurol 63:291, Waclawik,A.J., 2006
The "Eye-of-the-Tiger" Sign is Not Pathognomonic of the PANK2 Mutation
Arch Neurol 63:292-293, Kumar,N.,et al, 2006
Alexander Disease, Ventricular Garlands and Abnormalities of the Medulla and Spinal Cord
Neurol 66:494-498,468, van der Knaap,M.S.,et al, 2006
Internal and Cortical Border-Zone Infarction, Clinical and Diffusion-Weighted Imaging Features
Stroke 37:841-846, Yong,S.W.,et al, 2006
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006